Back to Search Start Over

Lactoferrin alleviates the adverse effects of early-life inflammation on depression in adults by regulating the activation of microglia.

Authors :
Wang W
An Q
Zou Y
Dai Y
Meng Q
Zhang Y
Source :
Molecular medicine (Cambridge, Mass.) [Mol Med] 2025 Feb 07; Vol. 31 (1), pp. 50. Date of Electronic Publication: 2025 Feb 07.
Publication Year :
2025

Abstract

Lactation is a crucial phase of brain development, and the events and nutrients during this period have long-term consequences for the occurrence of depression. This study investigated the effect and mechanism of lactoferrin (LF) deficiency during lactation on depression in adulthood. Lactation LF-deficient mice were established by nursing wild-type mice using LF systemic knockout mother mice. Additionally, 14-day-old mice were injected with lipopolysaccharide (LPS) and subjected to chronic unpredictable mild stress when they reached 6 weeks of age. The results show that lactation lactoferrin deficiency increases depression-like behavior in adult mice, and the mechanism is associated with heightened neuronal damage, abnormal microglial activation, and decreased BDNF in the hippocampus. In contrast, recombinant human lactoferrin promotes neuronal proliferation by upregulating ERK 1 and 2 phosphorylation and attenuates LPS-induced neuronal injury and microglial activation by inhibiting the activation of Toll-like receptor 4-nuclear factor-kappa B pathway in vitro. Our findings suggest that lactoferrin intake during lactation protects neurons by regulating microglial activation, thereby effectively reducing depressive symptoms in adults.<br />Competing Interests: Declarations. Ethics approval and consent to participate: The guidelines of the Institutional Animal Care and Use Committee (SYXK 2020-0052) were followed for the treatment of all mice. Additionally, experiments were approved by the Animal Experimentation Committee of China Agricultural University (Beijing, China), the issue number is AW40702202-4-6. Competing interests: The authors declare no competing interests.<br /> (© 2025. The Author(s).)

Details

Language :
English
ISSN :
1528-3658
Volume :
31
Issue :
1
Database :
MEDLINE
Journal :
Molecular medicine (Cambridge, Mass.)
Publication Type :
Academic Journal
Accession number :
39920579
Full Text :
https://doi.org/10.1186/s10020-025-01094-9